The HemOnc Pulse
Latest Episodes
What Is the Cost-Effectiveness of Pola-R-CHP in DLBCL?
Swetha Kambhampati, MD, and Nikhil Thiruvengadam,
Graham Collins, MBBS, on New Agents, Prognostic Models in Hodgkin Lymphoma
In the latest episode of The HemOnc Pulse, Graham
What Keeps Michael Bishop, MD, Up at Night When it Comes to CAR-T?
What is it about chimeric antigen receptor (CAR)
Laurie H. Sehn, MD, MPH, on the Game-Changing Bispecifics in Follicular Lymphoma
In the latest episode of The HemOnc Pulse, Laurie
Sanam Loghavi, MD, Tells Us Why 2022 was a Major Year for MDS
Sanam Loghavi, MD, stops by The HemOnc Pulse and
Elizabeth Brem, MD, on Which CLL Abstract From ASH 2022 Can’t Be Ignored
In the latest episode of The HemOnc Pulse, podcas
Ruben Mesa, MD, Discusses MPN Updates at ASH 2022 and the Evolution of the Disease
Ruben Mesa, MD, President and Executive Director
Drs. Hagop Kantarjian and Elias Jabbour Discuss Important AML, ALL Updates From ASH 2022
In the inaugural episode of The HemOnc Pulse, pod